Effect of Cytogenin, a Novel Immunomodulator, on Streptozotocin-induced Diabetes in Mice
Open Access
- 1 March 2005
- journal article
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 58 (3), 202-205
- https://doi.org/10.1038/ja.2005.24
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunctionDiabetologia, 2003
- Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes.Diabetes, 1999
- Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.Diabetes, 1998
- Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cellsDiabetologia, 1998
- Modulation of Macrophage Activity in Tumor Bearing Mice by Cytogenin.The Journal of Antibiotics, 1995
- Action of Cytogenin on Lymphoid Cells and Their Cytokine Production.The Journal of Antibiotics, 1995
- Antitumor Activity of Cytogenin.The Journal of Antibiotics, 1995
- Cytogenin, a novel antitumor substance.The Journal of Antibiotics, 1990
- Abilities of activated macrophages to manifest tumoricidal activity and to generate reactive nitrogen intermediates: A comparative study in vitro and ex vivoBiochemical and Biophysical Research Communications, 1989
- The Role of Thymic Immunity and Insulitis in the Development of Streptozocin-induced Diabetes in MiceDiabetes, 1984